Literature DB >> 7705939

Tyrosine phosphorylation as a marker for aberrantly regulated growth-promoting pathways in cell lines derived from head and neck malignancies.

M Cardinali1, H Pietraszkiewicz, J F Ensley, K C Robbins.   

Abstract

We have utilized a broad approach to address whether tyrosine kinases and the growth pathways they regulate might be functionally aberrant in squamous cell carcinomas (SCC) of the upper aerodigestive tract. This strategy involved assaying for evidence of tyrosine kinase action in lysates of cell lines representing SCC. Our findings revealed a spectrum of elevated tyrosine phosphorylation in SCC lines ranging from less than 2-fold to more than 10-fold above that of control human epidermal keratinocytes. Thus the ability to regulate growth and other pathways controlled by tyrosine phosphorylation was impaired in all the 19 lines examined. Assessment of the receptor for epidermal growth factor (EGF) revealed that its activity was elevated above normal in 14 of the 19 cell lines examined, suggesting that at least a portion of the increased tyrosine phosphorylation observed could be attributed to excessive EGF receptor activity. Our findings provide functional evidence that growth pathways are aberrantly regulated in cell lines representing SCC of the upper aerodigestive tract.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7705939     DOI: 10.1002/ijc.2910610117

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  47 in total

1.  Dendrimer-triglycine-EGF nanoparticles for tumor imaging and targeted nucleic acid and drug delivery.

Authors:  Quan Yuan; Eunmee Lee; W Andrew Yeudall; Hu Yang
Journal:  Oral Oncol       Date:  2010-08-21       Impact factor: 5.337

2.  EPS8 upregulates FOXM1 expression, enhancing cell growth and motility.

Authors:  Huixin Wang; Muy-Teck Teh; Youngmi Ji; Vyomesh Patel; Shahrzad Firouzabadian; Anisha A Patel; J Silvio Gutkind; W Andrew Yeudall
Journal:  Carcinogenesis       Date:  2010-03-29       Impact factor: 4.944

3.  In vitro 3-dimensional tumor model for radiosensitivity of HPV positive OSCC cell lines.

Authors:  Mei Zhang; Barbara Rose; C Soon Lee; Angela M Hong
Journal:  Cancer Biol Ther       Date:  2015-06-05       Impact factor: 4.742

4.  Semaphorin 4D cooperates with VEGF to promote angiogenesis and tumor progression.

Authors:  Hua Zhou; Nada O Binmadi; Ying-Hua Yang; Patrizia Proia; John R Basile
Journal:  Angiogenesis       Date:  2012-04-03       Impact factor: 9.596

5.  Cytotoxicity of allitinib, an irreversible anti-EGFR agent, in a large panel of human cancer-derived cell lines: KRAS mutation status as a predictive biomarker.

Authors:  Renato José Silva-Oliveira; Viviane Aline Oliveira Silva; Olga Martinho; Adriana Cruvinel-Carloni; Matias Eliseo Melendez; Marcela Nunes Rosa; Flávia Escremim de Paula; Luciano de Souza Viana; André Lopes Carvalho; Rui Manuel Reis
Journal:  Cell Oncol (Dordr)       Date:  2016-02-26       Impact factor: 6.730

6.  The Semaphorin 4D-Plexin-B1-RhoA signaling axis recruits pericytes and regulates vascular permeability through endothelial production of PDGF-B and ANGPTL4.

Authors:  Hua Zhou; Ying-Hua Yang; John R Basile
Journal:  Angiogenesis       Date:  2013-10-10       Impact factor: 9.596

Review 7.  The clinical application of DNA content and kinetic parameters in the treatment of patients with squamous cell carcinomas of the head and neck.

Authors:  J F Ensley
Journal:  Cancer Metastasis Rev       Date:  1996-03       Impact factor: 9.264

8.  A retroinhibition approach reveals a tumor cell-autonomous response to rapamycin in head and neck cancer.

Authors:  Panomwat Amornphimoltham; Vyomesh Patel; Kantima Leelahavanichkul; Robert T Abraham; J Silvio Gutkind
Journal:  Cancer Res       Date:  2008-02-15       Impact factor: 12.701

9.  Molecular phenotype predicts sensitivity of squamous cell carcinoma of the head and neck to epidermal growth factor receptor inhibition.

Authors:  Natalie R Young; Jing Liu; Carolyn Pierce; Tai-Fen Wei; Tatyana Grushko; Olufunmilayo I Olopade; Wanqing Liu; Christine Shen; Tanguy Y Seiwert; Ezra E W Cohen
Journal:  Mol Oncol       Date:  2012-11-14       Impact factor: 6.603

10.  Flavopiridol, a novel cyclin-dependent kinase inhibitor, suppresses the growth of head and neck squamous cell carcinomas by inducing apoptosis.

Authors:  V Patel; A M Senderowicz; D Pinto; T Igishi; M Raffeld; L Quintanilla-Martinez; J F Ensley; E A Sausville; J S Gutkind
Journal:  J Clin Invest       Date:  1998-11-01       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.